Timothy Hatlen to Double-Blind Method
This is a "connection" page, showing publications Timothy Hatlen has written about Double-Blind Method.
Connection Strength
0.094
-
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR). Eur Respir J. 2023 02; 61(2).
Score: 0.048
-
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial. Ann Intern Med. 2022 09; 175(9):1266-1274.
Score: 0.046